Addition of Etanercept and Extracorporeal Photopheresis to Standard GVHD Prophylaxis in Patients Undergoing Reduced Intensity Unrelated Donor Hematopoietic Stem Cell Transplant
Phase of Trial: Phase II
Latest Information Update: 03 Aug 2017
At a glance
- Drugs Etanercept (Primary) ; Methoxsalen; Mycophenolate mofetil; Mycophenolate mofetil; Tacrolimus; Tacrolimus
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- 03 Jul 2017 Status changed from active, no longer recruiting to completed.
- 05 Apr 2016 Planned End Date changed from 1 Sep 2015 to 1 May 2016 as per ClinicalTrials.gov record.
- 19 Dec 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.